Promoter hypermethylation of SHOX2 and SEPT9 is a potential biomarker for minimally invasive diagnosis in adenocarcinomas of the biliary tract.
Clin Epigenetics
; 8: 133, 2016.
Article
in En
| MEDLINE
| ID: mdl-27999621
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Biliary Tract Neoplasms
/
Adenocarcinoma
/
Homeodomain Proteins
/
Early Detection of Cancer
/
Septins
Type of study:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Screening_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Clin Epigenetics
Year:
2016
Document type:
Article